Logo image of DAVA

ENDAVA PLC- SPON ADR (DAVA) Stock Fundamental Analysis

NYSE:DAVA - New York Stock Exchange, Inc. - US29260V1052 - ADR - Currency: USD

16.28  +0.84 (+5.44%)

After market: 16.53 +0.25 (+1.54%)

Fundamental Rating

5

Taking everything into account, DAVA scores 5 out of 10 in our fundamental rating. DAVA was compared to 82 industry peers in the IT Services industry. DAVA has an average financial health and profitability rating. DAVA has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

DAVA had positive earnings in the past year.
In the past year DAVA had a positive cash flow from operations.
DAVA had positive earnings in each of the past 5 years.
Each year in the past 5 years DAVA had a positive operating cash flow.
DAVA Yearly Net Income VS EBIT VS OCF VS FCFDAVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

DAVA has a Return On Assets (0.56%) which is in line with its industry peers.
DAVA has a Return On Equity (0.84%) which is in line with its industry peers.
With a Return On Invested Capital value of 0.50%, DAVA perfoms like the industry average, outperforming 43.90% of the companies in the same industry.
DAVA had an Average Return On Invested Capital over the past 3 years of 9.56%. This is significantly below the industry average of 21.78%.
The last Return On Invested Capital (0.50%) for DAVA is well below the 3 year average (9.56%), which needs to be investigated, but indicates that DAVA had better years and this may not be a problem.
Industry RankSector Rank
ROA 0.56%
ROE 0.84%
ROIC 0.5%
ROA(3y)9.09%
ROA(5y)8.43%
ROE(3y)12.78%
ROE(5y)12.33%
ROIC(3y)9.56%
ROIC(5y)9.48%
DAVA Yearly ROA, ROE, ROICDAVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

DAVA has a Profit Margin (0.73%) which is comparable to the rest of the industry.
DAVA's Profit Margin has declined in the last couple of years.
DAVA has a Operating Margin of 0.76%. This is comparable to the rest of the industry: DAVA outperforms 42.68% of its industry peers.
In the last couple of years the Operating Margin of DAVA has declined.
With a Gross Margin value of 22.92%, DAVA is not doing good in the industry: 75.61% of the companies in the same industry are doing better.
DAVA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.76%
PM (TTM) 0.73%
GM 22.92%
OM growth 3Y-42.57%
OM growth 5Y-25.11%
PM growth 3Y-38.25%
PM growth 5Y-22.74%
GM growth 3Y-12.29%
GM growth 5Y-7.83%
DAVA Yearly Profit, Operating, Gross MarginsDAVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DAVA is creating some value.
Compared to 1 year ago, DAVA has more shares outstanding
The number of shares outstanding for DAVA has been increased compared to 5 years ago.
Compared to 1 year ago, DAVA has a worse debt to assets ratio.
DAVA Yearly Shares OutstandingDAVA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
DAVA Yearly Total Debt VS Total AssetsDAVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 3.10 indicates that DAVA is not in any danger for bankruptcy at the moment.
DAVA has a Altman-Z score (3.10) which is comparable to the rest of the industry.
DAVA has a debt to FCF ratio of 5.31. This is a neutral value as DAVA would need 5.31 years to pay back of all of its debts.
The Debt to FCF ratio of DAVA (5.31) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.25 indicates that DAVA is not too dependend on debt financing.
DAVA has a Debt to Equity ratio of 0.25. This is comparable to the rest of the industry: DAVA outperforms 57.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 5.31
Altman-Z 3.1
ROIC/WACC0.06
WACC8.04%
DAVA Yearly LT Debt VS Equity VS FCFDAVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.88 indicates that DAVA should not have too much problems paying its short term obligations.
DAVA has a better Current ratio (1.88) than 60.98% of its industry peers.
DAVA has a Quick Ratio of 1.88. This is a normal value and indicates that DAVA is financially healthy and should not expect problems in meeting its short term obligations.
DAVA has a better Quick ratio (1.88) than 63.41% of its industry peers.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.88
DAVA Yearly Current Assets VS Current LiabilitesDAVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

6

3. Growth

3.1 Past

DAVA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.75%.
DAVA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.26% yearly.
Looking at the last year, DAVA shows a decrease in Revenue. The Revenue has decreased by -6.79% in the last year.
The Revenue has been growing by 20.81% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-24.75%
EPS 3Y-4.56%
EPS 5Y8.26%
EPS Q2Q%54.55%
Revenue 1Y (TTM)-6.79%
Revenue growth 3Y18.4%
Revenue growth 5Y20.81%
Sales Q2Q%11.74%

3.2 Future

The Earnings Per Share is expected to grow by 19.04% on average over the next years. This is quite good.
The Revenue is expected to grow by 8.69% on average over the next years. This is quite good.
EPS Next Y9.29%
EPS Next 2Y11.16%
EPS Next 3Y13.92%
EPS Next 5Y19.04%
Revenue Next Year5.9%
Revenue Next 2Y5.8%
Revenue Next 3Y6.6%
Revenue Next 5Y8.69%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DAVA Yearly Revenue VS EstimatesDAVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
DAVA Yearly EPS VS EstimatesDAVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

DAVA is valuated reasonably with a Price/Earnings ratio of 10.85.
Based on the Price/Earnings ratio, DAVA is valued cheaper than 93.90% of the companies in the same industry.
DAVA's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.43.
A Price/Forward Earnings ratio of 8.64 indicates a reasonable valuation of DAVA.
Based on the Price/Forward Earnings ratio, DAVA is valued cheaper than 92.68% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.17, DAVA is valued rather cheaply.
Industry RankSector Rank
PE 10.85
Fwd PE 8.64
DAVA Price Earnings VS Forward Price EarningsDAVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

DAVA's Enterprise Value to EBITDA is on the same level as the industry average.
DAVA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. DAVA is cheaper than 65.85% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.62
EV/EBITDA 17.75
DAVA Per share dataDAVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
DAVA's earnings are expected to grow with 13.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.17
PEG (5Y)1.31
EPS Next 2Y11.16%
EPS Next 3Y13.92%

0

5. Dividend

5.1 Amount

No dividends for DAVA!.
Industry RankSector Rank
Dividend Yield N/A

ENDAVA PLC- SPON ADR

NYSE:DAVA (6/4/2025, 8:17:44 PM)

After market: 16.53 +0.25 (+1.54%)

16.28

+0.84 (+5.44%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)05-14 2025-05-14/bmo
Earnings (Next)N/A N/A
Inst Owners81.96%
Inst Owner Change-0.78%
Ins Owners0.58%
Ins Owner ChangeN/A
Market Cap967.92M
Analysts77.78
Price Target31.74 (94.96%)
Short Float %2.04%
Short Ratio1.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.34%
Min EPS beat(2)16.16%
Max EPS beat(2)18.52%
EPS beat(4)3
Avg EPS beat(4)11.92%
Min EPS beat(4)-4.63%
Max EPS beat(4)18.52%
EPS beat(8)7
Avg EPS beat(8)11.51%
EPS beat(12)10
Avg EPS beat(12)8.98%
EPS beat(16)14
Avg EPS beat(16)9.89%
Revenue beat(2)0
Avg Revenue beat(2)-2.02%
Min Revenue beat(2)-2.32%
Max Revenue beat(2)-1.71%
Revenue beat(4)0
Avg Revenue beat(4)-2.21%
Min Revenue beat(4)-2.59%
Max Revenue beat(4)-1.71%
Revenue beat(8)0
Avg Revenue beat(8)-1.81%
Revenue beat(12)1
Avg Revenue beat(12)-1.22%
Revenue beat(16)2
Avg Revenue beat(16)-0.85%
PT rev (1m)-5.72%
PT rev (3m)-21.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)8.94%
EPS NY rev (1m)0.45%
EPS NY rev (3m)5.77%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)-1.45%
Revenue NY rev (1m)-1.2%
Revenue NY rev (3m)-2.44%
Valuation
Industry RankSector Rank
PE 10.85
Fwd PE 8.64
P/S 0.94
P/FCF 21.62
P/OCF 18.87
P/B 1.09
P/tB 24.73
EV/EBITDA 17.75
EPS(TTM)1.5
EY9.21%
EPS(NY)1.88
Fwd EY11.58%
FCF(TTM)0.75
FCFY4.63%
OCF(TTM)0.86
OCFY5.3%
SpS17.24
BVpS14.87
TBVpS0.66
PEG (NY)1.17
PEG (5Y)1.31
Profitability
Industry RankSector Rank
ROA 0.56%
ROE 0.84%
ROCE 0.69%
ROIC 0.5%
ROICexc 0.54%
ROICexgc 2.69%
OM 0.76%
PM (TTM) 0.73%
GM 22.92%
FCFM 4.37%
ROA(3y)9.09%
ROA(5y)8.43%
ROE(3y)12.78%
ROE(5y)12.33%
ROIC(3y)9.56%
ROIC(5y)9.48%
ROICexc(3y)13.4%
ROICexc(5y)13.07%
ROICexgc(3y)36.97%
ROICexgc(5y)34.67%
ROCE(3y)13.1%
ROCE(5y)12.99%
ROICexcg growth 3Y-39.64%
ROICexcg growth 5Y-33.63%
ROICexc growth 3Y-51.15%
ROICexc growth 5Y-40.48%
OM growth 3Y-42.57%
OM growth 5Y-25.11%
PM growth 3Y-38.25%
PM growth 5Y-22.74%
GM growth 3Y-12.29%
GM growth 5Y-7.83%
F-Score3
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 5.31
Debt/EBITDA 3.6
Cap/Depr 12.38%
Cap/Sales 0.64%
Interest Coverage 0.82
Cash Conversion 84.86%
Profit Quality 602%
Current Ratio 1.88
Quick Ratio 1.88
Altman-Z 3.1
F-Score3
WACC8.04%
ROIC/WACC0.06
Cap/Depr(3y)34.69%
Cap/Depr(5y)33.75%
Cap/Sales(3y)1.53%
Cap/Sales(5y)1.59%
Profit Quality(3y)177.13%
Profit Quality(5y)174.51%
High Growth Momentum
Growth
EPS 1Y (TTM)-24.75%
EPS 3Y-4.56%
EPS 5Y8.26%
EPS Q2Q%54.55%
EPS Next Y9.29%
EPS Next 2Y11.16%
EPS Next 3Y13.92%
EPS Next 5Y19.04%
Revenue 1Y (TTM)-6.79%
Revenue growth 3Y18.4%
Revenue growth 5Y20.81%
Sales Q2Q%11.74%
Revenue Next Year5.9%
Revenue Next 2Y5.8%
Revenue Next 3Y6.6%
Revenue Next 5Y8.69%
EBIT growth 1Y-91.84%
EBIT growth 3Y-32%
EBIT growth 5Y-9.53%
EBIT Next Year50.57%
EBIT Next 3Y28.07%
EBIT Next 5Y22.66%
FCF growth 1Y-71.82%
FCF growth 3Y-16.15%
FCF growth 5Y11.7%
OCF growth 1Y-71.19%
OCF growth 3Y-14.93%
OCF growth 5Y8.87%